Cargando…
Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496297/ https://www.ncbi.nlm.nih.gov/pubmed/35862153 http://dx.doi.org/10.1161/JAHA.121.020782 |
| _version_ | 1784794234123976704 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9496297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94962972022-09-30 Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy J Am Heart Assoc Correction John Wiley and Sons Inc. 2022-07-05 /pmc/articles/PMC9496297/ /pubmed/35862153 http://dx.doi.org/10.1161/JAHA.121.020782 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correction Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title | Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title_full | Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title_fullStr | Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title_full_unstemmed | Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title_short | Correction to: Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors – a VALIDATE‐SWEDEHEART Substudy |
| title_sort | correction to: clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors – a validate‐swedeheart substudy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496297/ https://www.ncbi.nlm.nih.gov/pubmed/35862153 http://dx.doi.org/10.1161/JAHA.121.020782 |